Nd:YAG laser ablation of early pelvic endometriosis: A report of 61 cases

Jack M. Lomano, J M Lomano, Lomano JM
Lasers in surgery and medicine · 1987 · vol. 7(1) , pp. 56–60 · doi:10.1002/lsm.1900070110 · PMID:3573937 · W2169839680
article OA: closed CC0 ⤵ 17 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

Nd:YAG laser ablation of early pelvic endometriosis improved symptoms in 74% of 61 patients, with higher improvement rates observed in those receiving hormonal therapy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Sixty-one patients with mild or moderate endometriosis were treated with the Nd:YAG laser between May 1983 and March 1986. During the follow-up period, 31 patients received no supplemental medical treatment. Ten patients were given danazol, five for recurrence of pain and five because of the extent of the disease. Sixteen patients were given oral contraceptives, 12 for birth control and four for pain. Four patients received danazol plus oral contraceptives as concurrent therapy. Overall, symptoms improved following surgery for 45 patients (74%); two patients (3%) reported a worsening of symptoms, while 12 patients (20%) reported no change in their symptoms. The overall improvement rate was 65% for those receiving no hormonal treatment, 70% for those on danazol, 94% for those on oral contraceptives, and 75% for those on both contraceptives and danazol. This latter finding, however, is not significant because of the small patient sampling. Nevertheless, these findings reflect the benefit of laser ablation of early-stage pelvic endometriosis with or without the concurrent use of conservative medical therapy.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Laser Therapy Pelvic Neoplasms Endometriosis Female Follow-Up Studies Humans Pelvic Neoplasms Time Factors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (19)

Cited by (16)

SciLite annotations

chemicals 4
danazol danazol danazol danazol

Source provenance

europepmc
last seen: 2026-08-31T06:09:41.840111+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:09:30.565292+00:00
scilite
last seen: 2026-05-18T04:57:49.680383+00:00
License: CC0 · commercial use OK